| Gallinamide A | IC50 | 140.0 [1], 460.0 [2] |
| Citrusinine I | IC50 | 2200.0 [1] |
| Citrusinine I | Ki | 1000.0 [1] |
| 1,3,5-Trihydroxy-2,8-bis(3-methyl-2-butenyl)-10-methylacridine-9(10H)-one | IC50 | 3900.0 [1] |
| 1,3,5-Trihydroxy-2,8-bis(3-methyl-2-butenyl)-10-methylacridine-9(10H)-one | Ki | 1200.0 [1] |
| Cathepsin inhibitor 1 | IC50 | 199.53 [1] |
| Citrusinine II | IC50 | 10000.0 [1] |
| Citrusinine II | Ki | 4200.0 [1] |
| 5-Tert-butyl-N-[(2S)-1-(cyanomethylamino)-3-(3-methylphenyl)-1-oxopropan-2-yl]-2-methylpyrazole-3-carboxamide | IC50 | 398.11 [1] |
| Glycocitrine-IV | IC50 | 2200.0 [1] |
| Glycocitrine-IV | Ki | 1100.0 [1] |
| Citbrasine | IC50 | 1200.0 [1] |
| Citbrasine | Ki | 200.0 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]benzamide | IC50 | 794.33 [1] |
| 1,3,5-Trihydroxy-4-methoxy-10-methyl-2,8-bis(3-methylbut-2-enyl)acridin-9-one | IC50 | 2500.0 [1] |
| 1,3,5-Trihydroxy-4-methoxy-10-methyl-2,8-bis(3-methylbut-2-enyl)acridin-9-one | Ki | 500.0 [1] |
| 4,9-Dihydroxy-2-(2-hydroxypropan-2-yl)-11-methoxy-10-methyl-2,3-dihydrofuro[3,2-b]acridin-5-one | IC50 | 5200.0 [1] |
| 4,9-Dihydroxy-2-(2-hydroxypropan-2-yl)-11-methoxy-10-methyl-2,3-dihydrofuro[3,2-b]acridin-5-one | Ki | 4400.0 [1] |
| Glycocitrine-I | IC50 | 25000.0 [1] |
| Glycocitrine-I | Ki | 10000.0 [1] |
| 3,5,8-Trihydroxy-6-methoxy-2,2,7-trimethyl-3,4-dihydropyrano[2,3-a]acridin-12-one | IC50 | 2800.0 [1] |
| 3,5,8-Trihydroxy-6-methoxy-2,2,7-trimethyl-3,4-dihydropyrano[2,3-a]acridin-12-one | Ki | 1700.0 [1] |
| 2-(4-Butylphenyl)-1H-quinolin-4-one | IC50 | 5200.0 [1] |
| 2-(4-Butylphenyl)-1H-quinolin-4-one | Ki | 800.0 [1] |
| 3-Phenylmethoxy-10H-acridin-9-one | IC50 | 3600.0 [1] |
| 3-Phenylmethoxy-10H-acridin-9-one | Ki | 1300.0 [1] |
| 2-Nitro-7-phenylmethoxy-10H-acridin-9-one | IC50 | 1700.0 [1] |
| 2-Nitro-7-phenylmethoxy-10H-acridin-9-one | Ki | 400.0 [1] |
| 3-(3-Methoxy-4-phenylmethoxyanilino)naphthalene-2-carboxylic acid | IC50 | 1800.0 [1] |
| 3-(3-Methoxy-4-phenylmethoxyanilino)naphthalene-2-carboxylic acid | Ki | 1100.0 [1] |
| 3-(3-Nitro-4-phenylmethoxyanilino)naphthalene-2-carboxylic acid | IC50 | 1000.0 [1] |
| 3-(3-Nitro-4-phenylmethoxyanilino)naphthalene-2-carboxylic acid | Ki | 800.0 [1] |
| Telaprevir | IC50 | 1350.0 [1] |
| Boceprevir | IC50 | 75.0 [1] |
| Odanacatib | IC50 | 762.0 [1] |
| 2-Phenylquinolin-4-ol | IC50 | 4700.0 [1] |
| Relacatib | Ki | 0.06 [1] |
| (1R,21S,24S)-21-Tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.14,7.06,11]heptacosa-6(11),7,9-triene-24-carboxamide | IC50 | 10000.0 [1] |
| 2-((4-Methoxyphenyl)amino)benzoic acid | IC50 | 50000.0 [1] |
| 11-Hydroxynoracronycine | IC50 | 48000.0 [1] |
| 2-Undecyl-4(1H)-quinolinone | IC50 | 9900.0 [1] |
| Grassystatin A | IC50 | 10000.0 [1] |
| Cruzain-IN-1 | IC50 | 239.88 [1] |
| 9-(3,5-Difluorophenyl)-6-(ethylamino)-2-purinecarbonitrile | IC50 | 70794.58 [1] |
| 2-(p-Methylphenyl)quinolin-4(1H)-one | IC50 | 5000.0 [1] |
| [(2S)-3,3-Dimethyl-1-[3-[4-(trifluoromethyl)phenyl]pyrazol-1-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-(1H-pyrazol-5-ylamino)heptan-3-yl]carbamate | IC50 | 170.0 [1] |
| N-[(2S)-3-Cyclohexyl-1-[2-(4-methoxyanilino)ethylamino]-1-oxopropan-2-yl]-5-[3-(trifluoromethyl)phenyl]furan-2-carboxamide | Ki | 20000.0 [1] |
| N-[(2S)-4-Methyl-1-oxo-1-[[(4S)-3-oxo-1-pyridin-2-ylsulfonylazepan-4-yl]amino]pentan-2-yl]-1-benzofuran-2-carboxamide | Ki | 1.8 [1] |
| [(3S)-4,4-Dimethyl-2-oxooxolan-3-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 79.0 [1] |
| [(2R)-1-[5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-yl]-3,3-dimethylbutan-2-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 34000.0 [1] |
| [(2R)-3,3-Dimethyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)butan-2-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 1600.0 [1] |
| [(2S)-3,3-Dimethyl-1-[4-[4-(trifluoromethyl)phenyl]pyrazol-1-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-(1H-pyrazol-5-ylamino)heptan-3-yl]carbamate | IC50 | 430.0 [1] |
| [(2S)-3,3-Dimethyl-1-[4-[4-(trifluoromethyl)phenyl]imidazol-1-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-(1H-pyrazol-5-ylamino)heptan-3-yl]carbamate | IC50 | 130.0 [1] |
| [(2R)-3,3-Dimethyl-1-[5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 5000.0 [1] |
| [(2R)-3,3-Dimethyl-1-[5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-(1H-pyrazol-5-ylamino)heptan-3-yl]carbamate | IC50 | 1200.0 [1] |
| [(2S)-3,3-Dimethyl-1-[4-[4-(trifluoromethyl)phenyl]imidazol-1-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-(1,3-thiazol-2-ylamino)heptan-3-yl]carbamate | IC50 | 36000.0 [1] |
| 6-[4-[3-(4-Ethylpiperazin-1-yl)propoxy]-3-(trifluoromethyl)phenyl]-1-methylimidazo[4,5-c]pyridine-4-carbonitrile | IC50 | 10000.0 [1] |
| 2-Methoxy-7-nitroacridin-9(10H)-one | IC50 | 2000.0 [1] |
| [(2S)-3,3-Dimethyl-1-[2-oxo-3-[4-(trifluoromethyl)phenyl]imidazolidin-1-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-(1H-pyrazol-5-ylamino)heptan-3-yl]carbamate | IC50 | 1700.0 [1] |
| [(2R)-1-[5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-yl]-3,3-dimethylbutan-2-yl] N-[(3S)-1,2-dioxo-1-(pyridin-3-ylmethylamino)heptan-3-yl]carbamate | IC50 | 14000.0 [1] |
| 1-Methyl-6-[4-(2-piperidin-4-ylethoxy)-3-(trifluoromethyl)phenyl]imidazo[4,5-c]pyridine-4-carbonitrile | IC50 | 10000.0 [1] |
| 6-[4-[3-(Dimethylamino)propoxy]-3-(trifluoromethyl)phenyl]-1-methylimidazo[4,5-c]pyridine-4-carbonitrile | IC50 | 10000.0 [1] |
| [(2R)-3,3-Dimethyl-1-[5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-[(2-oxo-1,3-oxazolidin-3-yl)amino]heptan-3-yl]carbamate | IC50 | 7100.0 [1] |
| (3S)-19-Chloro-N-(1-cyanocyclopropyl)-5-oxo-9-(trifluoromethyl)-12,17-dioxa-4-azatricyclo[16.2.2.06,11]docosa-1(20),6(11),7,9,18,21-hexaene-3-carboxamide | IC50 | 1043.0 [1] |
| [(2S)-3,3-Dimethyl-1-[3-[4-(trifluoromethyl)phenyl]pyrazol-1-yl]butan-2-yl] N-[(3S)-1-(1,2-oxazol-5-ylmethylamino)-1,2-dioxoheptan-3-yl]carbamate | IC50 | 36000.0 [1] |
| [(2R)-3-Methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)butan-2-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 5600.0 [1] |
| [(2R)-1-[5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-yl]-3,3-dimethylbutan-2-yl] N-[(3S)-1,2-dioxo-1-(1H-pyrazol-5-ylamino)heptan-3-yl]carbamate | IC50 | 230000.0 [1] |
| [(2R)-3,3-Dimethyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentan-2-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 2800.0 [1] |
| [(2S)-3,3-Dimethyl-1-[3-[4-(trifluoromethyl)phenyl]pyrazol-1-yl]butan-2-yl] N-[(3S)-1,2-dioxo-1-(pyridin-2-ylamino)heptan-3-yl]carbamate | IC50 | 4500.0 [1] |
| 2-(Furan-2-yl)-1H-quinolin-4-one | IC50 | 4700.0 [1] |
| [(3S)-4,4-Dimethyl-2-oxopyrrolidin-3-yl] N-[(3S)-1,2-dioxo-1-[[(1R)-1-phenylethyl]amino]heptan-3-yl]carbamate | IC50 | 29.0 [1] |
| 2-Anilino-3-methoxybenzoic acid | IC50 | 50000.0 [1] |
| (3R,4R)-4-(2,3-Dimethylphenoxy)piperidin-3-ol | IC50 | 100000.0 [1] |
| (4S,5R)-4-(2,3-Dimethylphenoxy)-6-oxa-1-azabicyclo[3.2.1]octan-7-one | IC50 | 131.0 [1] |
| 2-(3-Benzyloxyphenylamino)benzoic acid | IC50 | 2100.0 [1] |
| 2-Anilino-5-nitrobenzoic acid | IC50 | 10000.0 [1] |
| (4S,5S)-4-(2,3-Dimethylphenoxy)-6-oxa-1-azabicyclo[3.2.1]octan-7-one | IC50 | 3317.0 [1] |
| (4S,5R)-4-Phenoxy-6-oxa-1-azabicyclo[3.2.1]octan-7-one | IC50 | 158.0 [1] |
| (4S,5R)-4-Phenylmethoxy-6-oxa-1-azabicyclo[3.2.1]octan-7-one | IC50 | 1289.0 [1] |
| (4S,5R)-4-(2-Methylpropoxy)-6-oxa-1-azabicyclo[3.2.1]octan-7-one | IC50 | 894.0 [1] |
| (4S,5S)-4-Bromo-6-oxa-1-azabicyclo[3.2.1]octan-7-one | IC50 | 10000.0 [1] |
| 1-[4-[4-[(1S)-1-[[(2S)-1-[[(1S)-1-Cyano-2-(4-cyano-2-fluorophenyl)ethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-2,2,2-trifluoroethyl]phenyl]phenyl]cyclopropane-1-carboxamide | IC50 | 79.0 [1] |
| (2S)-N-[(1S)-1-Cyano-2-(4-cyano-2-fluorophenyl)ethyl]-2-[[(1S)-1-[4-[4-[(1R)-2,2-difluoro-1-hydroxyethyl]phenyl]phenyl]-2,2,2-trifluoroethyl]amino]-3-methylbutanamide | IC50 | 69.0 [1] |
| (2S)-N-[(1S)-1-Cyano-2-(4-cyano-2-fluorophenyl)ethyl]-3-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]butanamide | IC50 | 28.0 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]cyclohexanecarboxamide | IC50 | 6309.57 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]cyclohexene-1-carboxamide | IC50 | 398.11 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]cycloheptanecarboxamide | IC50 | 6309.57 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]-4-methylbenzamide | IC50 | 1000.0 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]-3-methylbenzamide | IC50 | 794.33 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]-2-methylbenzamide | IC50 | 5011.87 [1] |
| 3-Chloro-N-[(2S)-3-(3-chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]benzamide | IC50 | 199.53 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]-2,5-dimethylbenzamide | IC50 | 1584.89 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]-2,3-dimethylbenzamide | IC50 | 3981.07 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]-3,5-dimethylbenzamide | IC50 | 199.53 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]naphthalene-1-carboxamide | IC50 | 3981.07 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]-5,6,7,8-tetrahydronaphthalene-1-carboxamide | IC50 | 10000.0 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]quinoline-4-carboxamide | IC50 | 3162.28 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]-3,7-dimethylnaphthalene-1-carboxamide | IC50 | 1000.0 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]-1,3-dimethylpyrazole-4-carboxamide | IC50 | 1258.93 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]-2,5-dimethylpyrazole-3-carboxamide | IC50 | 1258.93 [1] |